Juan Mo Selected Research

Juan Mo Research Topics

Disease

7	Neoplasms (Cancer) 12/2023 - 01/2019
6	Infections 01/2022 - 01/2014
3	Carcinogenesis 01/2022 - 04/2006
3	Retinitis 07/2019 - 06/2014
3	Obesity 07/2011 - 01/2009
3	Pediatric Obesity 07/2011 - 01/2009
2	Neurofibroma 01/2022 - 01/2018
2	Hypertension (High Blood Pressure) 05/2020 - 12/2017
2	Virus Diseases (Viral Diseases) 07/2019 - 06/2014
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2019 - 01/2019
2	Inflammation (Inflammations) 01/2018 - 01/2018
2	Insulin Resistance 07/2011 - 09/2010
1	Neoplasm Metastasis (Metastasis) 02/2023
1	Asymptomatic Infections 03/2022
1	Neurilemmoma (Schwannoma) 10/2020
1	COVID-19 05/2020
1	Pneumonia (Pneumonitis) 05/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020
1	Cytomegalovirus Retinitis 07/2019
1	Familial paroxysmal dystonia 01/2019
1	Neurofibrosarcoma (MPNST) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Choroidal Neovascularization 12/2017
1	Hemorrhage 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2017
1	Arteriosclerosis 12/2017
1	Microaneurysm 12/2017
1	Necrosis 06/2014
1	Oral Lichen Planus 04/2006
1	Squamous Cell Carcinoma of Head and Neck 04/2006
1	Leukoplakia 04/2006

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 07/2019 - 06/2014
4	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2018
2	AntigensIBA 08/2023 - 07/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2014
2	Neurofibromin 1 (Neurofibromin)IBA 01/2022 - 01/2019
2	InflammasomesIBA 01/2018 - 01/2018
2	oxidized low density lipoproteinIBA 07/2011 - 09/2010
2	AdiponectinIBA 07/2011 - 01/2009
2	Triglycerides (Triacylglycerol)IBA 07/2011 - 09/2010
2	CholesterolIBA 07/2011 - 09/2010
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 09/2010
2	Insulin (Novolin)FDA Link 07/2011 - 09/2010
2	HDL CholesterolIBA 07/2011 - 09/2010
2	LDL CholesterolIBA 07/2011 - 09/2010
2	LeptinIBA 09/2010 - 09/2009
1	Econazole FDA LinkGeneric 12/2023
1	CarbohydratesIBA 08/2023
1	FluorineIBA 08/2023
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 08/2023
1	PolymersIBA 02/2023
1	SialyltransferasesIBA 02/2023
1	C-Reactive ProteinIBA 03/2022
1	CreatineIBA 03/2022
1	AntibodiesIBA 03/2022
1	Fibrinogen (Factor I)FDA Link 03/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022
1	alpha2 Subunit Collagen Type IIBA 01/2022
1	6-methyladenineIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	CycloleucineIBA 01/2022
1	MitogensIBA 01/2022
1	Cyclic NucleotidesIBA 01/2022
1	Therapeutic UsesIBA 10/2020
1	Neurofibromin 2 (Merlin)IBA 10/2020
1	APTIBA 05/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 07/2019
1	NestinIBA 07/2019
1	Caspase 3 (Caspase-3)IBA 07/2019
1	Pentylenetetrazole (Metrazol)IBA 01/2019
1	human PRRT2 proteinIBA 01/2019
1	Proteolysis Targeting ChimeraIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Stem Cell FactorIBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 12/2017
1	CaspasesIBA 10/2014
1	Small Interfering RNA (siRNA)IBA 06/2014
1	Chloroquine (Aralen)FDA LinkGeneric 01/2014
1	Retinal Pigments (Pigments, Visual)IBA 01/2014
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2014
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2006

Therapy/Procedure

4	Therapeutics 08/2023 - 01/2019
1	Immunotherapy 08/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2020